Hematopoietic Progenitor Cells
Hematopoietic Progenitor Cells
批准号:
6740141
负责人:
Elizabeth J Shpall
金额:
$22.65万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-17 至 2008-03-31
关键词:
CD34 moleculebone marrowclinical researchclinical trial phase IIcord bloodhematopoietic stem cellshematopoietic tissue transplantationhuman subjecthuman therapy evaluationleukocyte activation /transformationneutrophilpatient oriented researchpostoperative complicationsstem cell transplantationtransplant rejectiontransplantation immunology
中文摘要
描述(由申请人提供):脐带血(CB)用于恢复缺乏同胞或无关供体的骨髓移植患者的造血。CB的主要缺点是低细胞剂量,导致中性粒细胞植入延迟和植入失败率高。该授权的主要假设是,在移植前离体扩增的CB祖细胞将提供比未操作的CB更快的中性粒细胞植入和更少的植入失败。有两个群体已被提出负责快速骨髓恢复:1)成熟的祖细胞,和2)原始造血干细胞。在这项资助中,我们将进行三个连续的II期临床试验,以评估CB移植物体外扩增产生成熟的祖细胞或原始干细胞。第一项试验是之前R 01的延续,将评估CB移植物,其中定向CD 34+前体已被选择性扩增。第二项试验将评估CB移植物,其中更多的原始CB细胞被扩大,使用早期作用的生长因子和资助中描述的新技术。根据这些研究的结果,第三项试验将随机分配患者接受未操作与扩增的CB祖细胞,使用前两项试验中的扩增方法,导致最快的植入。我们预计感染性并发症将是这些试验中发病率和死亡率的主要原因。尽管扩增的CB可以加速中性粒细胞植入并减少移植后早期的感染,但它可能不会影响与延迟免疫恢复相关的感染。CB接受者的免疫重建延迟是经常报道的。这是可能的,CB纯化和扩增方法提出了这项授权,这导致选择性损失的淋巴细胞,可能会进一步损害免疫重建。因此,我们计划全面评估参加拟议试验的CB受体的免疫重建。将研究一般免疫功能和CMV特异性免疫重建,因为有多种免费检测方法可用,并且将进行这些检测的合作研究者具有专业知识。通过在第三项试验中对患者进行随机分组,我们将能够估计CB扩增技术的相对功效以及未操作与扩增CB受体的免疫重建。
英文摘要
DESCRIPTION (provided by applicant): Umbilical cord blood (CB) is used to restore hematopoiesis in bone marrow transplant patients lacking sibling or unrelated donors. A major disadvantage of CB is the low cell dose with resultant delays in neutrophil engraftment and a high rate of engraftment failure. The major hypothesis of this grant is that CB progenitors expanded ex vivo prior to transplantation will provide more rapid neutrophil engraftment and less engraftment failure than unmanipulated CB. There are two populations that have been proposed to be responsible for rapid myeloid recovery: 1) mature progenitor cells, and 2) primitive hematopoietic stem cells. In this grant we will conduct three sequential phase II clinical trials to evaluate CB grafts expanded ex vivo to generate mature progenitors or primitive stem cells. The first trial, a continuation of the previous R01, will evaluate CB grafts in which committed CD34+ precursors have been selectively expanded. The second trial will evaluate CB grafts in which more primitive CB cells are expanded, using earlier-acting growth factors and novel technology described in the grant. Based upon the findings of these studies, the third trial will randomize patients to receive CB progenitors which are unmanipulated vs. expanded, using the expansion methodology in the first two trials that results in the fastest engraftment. We anticipate that infectious complications will be a major cause of morbidity and mortality in these trials. Although expanded CB may hasten neutrophil engraftment and reduce infections early posttransplant, it may not affect infections associated with delayed immune recovery. Delays in immune reconstitution in CB recipients are frequently reported. It is possible that the CB purification and expansion methods proposed in this grant, which result in selective loss of lymphoid cells, could further compromise immune reconstitution. Thus, we plan to comprehensively evaluate the immune reconstitution of CB recipients enrolled on the proposed trials. General immune function and CMV-specific immune reconstitution will be studied, because of the multiple, complimentary assays available and the expertise of the co-investigators who will be performing them. By randomizing patients in the third trial, we will be able to make an estimate of the relative efficacy of CB expansion technology as well as immune reconstitution in recipients of unmanipulated vs. expanded CB.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
-
批准号:10911713
-
项目类别:
-
资助金额:$91.86万
-
财政年份:2023
-
负责人:Elizabeth J Shpall
-
依托单位:
Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD
-
批准号:10478151
-
项目类别:
-
资助金额:$53.24万
-
财政年份:2011
-
负责人:Elizabeth J Shpall
-
依托单位:
Cord Blood Expansion and Homing to Improve Engraftment
-
批准号:9340308
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2011
-
负责人:Elizabeth J Shpall
-
依托单位:
Administrative Core
-
批准号:10247037
-
项目类别:
-
资助金额:$19.04万
-
财政年份:2011
-
负责人:Elizabeth J Shpall
-
依托单位:
Cord Blood Expansion and Homing to Improve Engraftment
-
批准号:8555381
-
项目类别:
-
资助金额:$53.44万
-
财政年份:2011
-
负责人:Elizabeth J Shpall
-
依托单位:
Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD
-
批准号:10247041
-
项目类别:
-
资助金额:$53.2万
-
财政年份:2011
-
负责人:Elizabeth J Shpall
-
依托单位:
Administrative, Regulatory and Cord Blood Bank
-
批准号:9340312
-
项目类别:
-
资助金额:$47.07万
-
财政年份:2011
-
负责人:Elizabeth J Shpall
-
依托单位:
Administrative, Regulatory and Cord Blood Bank
-
批准号:8555385
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2011
-
负责人:Elizabeth J Shpall
-
依托单位:
Administrative Core
-
批准号:10478144
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2011
-
负责人:Elizabeth J Shpall
-
依托单位:
Good Manufacturing Practice (GMP) and Immune Assessment Core
-
批准号:8000169
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2010
-
负责人:Elizabeth J Shpall
-
依托单位:
DETECTION OF MALIGNANT CELLS IN MARROW & PBPC FRACTIONS
-
批准号:2863385
-
项目类别:
-
资助金额:$13.3万
-
财政年份:1998
-
负责人:Elizabeth J Shpall
-
依托单位:
DETECTION OF MALIGNANT CELLS IN MARROW & PBPC FRACTIONS
-
批准号:2896799
-
项目类别:
-
资助金额:$6.85万
-
财政年份:1998
-
负责人:Elizabeth J Shpall
-
依托单位:
13 Stem Cell Transplantation and Cellular Therapy
-
批准号:10655557
-
项目类别:
-
资助金额:$1.87万
-
财政年份:1996
-
负责人:Elizabeth J Shpall
-
依托单位:
13 Stem Cell Transplantation and Cellular Therapy
-
批准号:10212276
-
项目类别:
-
资助金额:$1.87万
-
财政年份:1996
-
负责人:Elizabeth J Shpall
-
依托单位:
13 Stem Cell Transplantation and Cellular Therapy
-
批准号:10467009
-
项目类别:
-
资助金额:$1.87万
-
财政年份:1996
-
负责人:Elizabeth J Shpall
-
依托单位:
HEMATOPOIETIC PROGENITOR CELLS
-
批准号:2102241
-
项目类别:
-
资助金额:$12.38万
-
财政年份:1993
-
负责人:Elizabeth J Shpall
-
依托单位:
HEMATOPOIETIC PROGENITOR CELLS
-
批准号:2882393
-
项目类别:
-
资助金额:$16.25万
-
财政年份:1993
-
负责人:Elizabeth J Shpall
-
依托单位:
Hematopoietic Progenitor Cells - Cord Blood
-
批准号:8610885
-
项目类别:
-
资助金额:$30.07万
-
财政年份:1993
-
负责人:Elizabeth J Shpall
-
依托单位:
HEMATOPOIETIC PROGENITOR CELLS
-
批准号:2599535
-
项目类别:
-
资助金额:$15.93万
-
财政年份:1993
-
负责人:Elizabeth J Shpall
-
依托单位:
HEMATOPOIETIC PROGENITOR CELLS
-
批准号:2102242
-
项目类别:
-
资助金额:$14.77万
-
财政年份:1993
-
负责人:Elizabeth J Shpall
-
依托单位:
海外基金